• Quotes
  • Shortcuts
The Executive's Internet
Sun, Oct 25th
editor corner icon Editor's Corner | Archive
Steps to Help You Get Out of Your Own Way: These research-based tips will help you slow down, fight the fog, and improve both your home life and work life. Patricia
icon
GoogleAmazonWikipedia
site of the day icon Site of the Day | Archive
Information is Beautiful
Distilling the world's data, information & knowledge into beautiful infographics & visualizations


spacerspacer

 

 BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Stimulus Dow'. (Return)

CNBC FinanceOct 25, 2020
Dow futures fall 100 points after U.S. coronavirus cases surge to record high
The Dow and the S&P 500 are coming off their first losing week in four as talks over the next coronavirus stimulus package dragged on.

Google Business NewsOct 25, 2020
Pelosi and Meadows trade accusations over stimulus talks in sign deal remains elusive - CNN
Pelosi and Meadows trade accusations over stimulus talks in sign deal remains elusive  CNNSecond stimulus check updates: Pelosi not giving up on COVID-19 bill  Chicago TribuneSecond stimulus checks: Pelosi still hoping to strike deal before election  WGHP FOX 8 GreensboroView Full Coverage on Google News

RELATED ARTICLES
Pelosi, White House Say Each ‘Moving the Goalposts' on Stimulus (Yahoo Business)

Yahoo BusinessOct 25, 2020
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and the impasse on fiscal stimulus.After declining in the first three sessions of the week, the iShares Nasdaq Biotechnology Etf (NASDAQ: IBB) rebounded in the next two, thereby recouping some of the losses.Biogen Inc's (NASDAQ: BIIB) third-quarter report headlined the biopharma earnings news flow of the week. Although the initial reaction was positive due to the better-than-expected headline numbers, the stock came under selling pressure subsequently, as investors fretted over accelerating decline in Spinraza sales and the looming binary event for Alzheimer's treatment candidate aducanumab.On the coronavirus vaccine front, AstraZeneca plc (NASDAQ: AZN) experienced another scare as a trial participant was reported as dead in Brazil. The U.K. biopharma, however, was vindicated as reports later said the said participant was administered placebo and not the investigational vaccine.Moderna Inc (NASDAQ: MRNA) completed enrollment in its Phase 3 COVE study, with the company now looking ahead to the interim readout.Gilead Sciences, Inc.'s (NASDAQ: GILD) Veklury was accorded full FDA approval during the week.Expectedly, Zosano Pharma Corp (NASDAQ: ZSAN) was handed down a complete response letter for the NDA for its migraine patch. The penny stock slumped about 40% at one point in time in the week before recovering some of

CNBC FinanceOct 23, 2020
Dow falls 200 points on concern about stimulus, Intel leads tech lower
U.S. stocks fell as investors weighed the potential for additional fiscal stimulus and Intel shares led the broader tech sector lower.
TRENDING TAGS
Covid-19Cases infections Health early vaccine
coronaviruscases record pandemic White House
PandemicWhite House coronavirus chief going
reporting
BrandsDunkin talks go private Inspire
StockBuy Market Right These Week
TrumpBiden Rally NBC how
talksBrands Dunkin go private CNN
casescoronavirus COVID-19 record high White
Dowcoronavirus cases record high Meadows

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC